Description
Description Stylage XL Lidocaine (2x1ml)
Stylage XL lidocaine 2x1ml designates a filler product developed by the French laboratory Vivacy and distributed by Fillers. It is a monophasic resorbable device ideal for moisturizing and treating fine lines or imperfections in the dermis.
Thanks to a special design process, in line with the latest biological and scientific advances, Stylage XL 2x1ml lidocaine marks the perfect filler gel based on local anesthetic. Stylage XL 2x1ml lidocaine is an injectable able to restore the face to its natural look. This filler also helps to increase or restore facial volumes.
Product property
Stylage XL lidocaine 2x1ml is a product developed according to European medical standards. It is a product that is the subject of a qualified certificate. By its component, this product is necessary to harmoniously restore the balance of facial features. Stylage XL 2x1ml lidocaine lifts the chin, jaws, cheeks, cheekbones, which promotes a more youthful appearance.
Target areas
This product is injected into different areas of the body, more particularly into the following parts:
- Deep Wrinkles
- cheekbones
- Play
- Furrows
- Folds of bitterness
- Volume restore
- Chin
- Jaws
- face oval
Not recommended for:
- People sensitive to components
- Pregnant women
- Minors
Application Protocol
This product must be used by an authorized professional. The injection can be performed with a needle in the deep dermis or with the Hyaluron Pen (available on our store).
Stylage XL 2x1ml lidocaine, what possible effects after treatment?
After the injection, the effects are visible immediately. This product allows an immediate filling of moderate volumizer. Stylage’s IPN-Like technology ensures a duration of effectiveness of up to 12 months.
Feature of Stylage XL Lidocaine (2x1ml)
A box contains:
- Two 1ml syringes
- A 27G ½ thin-walled needle
Composition
- A cross-linked hyaluronic acid concentration of 26mg/ml
- Lidocaine concentration: 3.0 mg
*Results vary and not guaranteed. These may vary depending on the individual and the mode of injection.
